Kahn Brothers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10M | Buy |
174,152
+3,771
| +2% | +$217K | 1.59% | 16 |
|
|
2026
Q1 | $10.3M | Sell |
170,381
-31,815
| -16% | -$1.85M | 1.83% | 16 |
|
|
2025
Q4 | $10.9M | Sell |
202,196
-70,138
| -26% | -$3.37M | 1.93% | 13 |
|
|
2025
Q3 | $12.3M | Sell |
272,334
-278,349
| -51% | -$13M | 2.31% | 13 |
|
|
2025
Q2 | $25.5M | Sell |
550,683
-46,745
| -8% | -$2.29M | 5.12% | 9 |
|
|
2025
Q1 | $36.4M | Sell |
597,428
-92,824
| -13% | -$5.41M | 7.37% | 7 |
|
|
2024
Q4 | $39M | Sell |
690,252
-135,856
| -16% | -$7.59M | 8.48% | 4 |
|
|
2024
Q3 | $42.7M | Sell |
826,108
-1,150
| -0.1% | -$53.9K | 7.36% | 7 |
|
|
2024
Q2 | $34.4M | Sell |
827,258
-4,733
| -0.6% | -$212K | 5.77% | 7 |
|
|
2024
Q1 | $45.1M | Sell |
831,991
-1,925
| -0.2% | -$98.1K | 6.69% | 6 |
|
|
2023
Q4 | $42.8M | Sell |
833,916
-17,783
| -2% | -$933K | 6.74% | 7 |
|
|
2023
Q3 | $49.5M | Sell |
851,699
-19,545
| -2% | -$1.2M | 7.72% | 7 |
|
|
2023
Q2 | $61.3M | Sell |
871,244
-29,312
| -3% | -$1.97M | 8.99% | 4 |
|
|
2023
Q1 | $62.4M | Sell |
900,556
-13,445
| -1% | -$948K | 8.98% | 3 |
|
|
2022
Q4 | $65.8M | Sell |
914,001
-10,092
| -1% | -$761K | 8.66% | 5 |
|
|
2022
Q3 | $65.7M | Sell |
924,093
-4,772
| -0.5% | -$346K | 10.24% | 1 |
|
|
2022
Q2 | $71.5M | Buy |
928,865
+3,137
| +0.3% | +$239K | 9.63% | 3 |
|
|
2022
Q1 | $67.6M | Buy |
925,728
+4,125
| +0.4% | +$277K | 8.58% | 4 |
|
|
2021
Q4 | $57.5M | Buy |
921,603
+47,873
| +5% | +$2.81M | 7.89% | 7 |
|
|
2021
Q3 | $51.7M | Sell |
873,730
-19,315
| -2% | -$1.27M | 7.28% | 9 |
|
|
2021
Q2 | $58.3M | Buy |
893,045
+46,709
| +6% | +$3.05M | 8.35% | 3 |
|
|
2021
Q1 | $53.4M | Sell |
846,336
-17,901
| -2% | -$1.11M | 8.27% | 5 |
|
|
2020
Q4 | $53.6M | Sell |
864,237
-71,740
| -8% | -$4.41M | 9.35% | 2 |
|
|
2020
Q3 | $56.4M | Sell |
935,977
-79,827
| -8% | -$4.8M | 10.7% | 2 |
|
|
2020
Q2 | $59.7M | Sell |
1,015,804
-10,405
| -1% | -$622K | 10.09% | 3 |
|
|
2020
Q1 | $57.2M | Sell |
1,026,209
-27,523
| -3% | -$1.68M | 10.46% | 3 |
|
|
2019
Q4 | $67.6M | Sell |
1,053,732
-19,028
| -2% | -$1.09M | 8.2% | 5 |
|
|
2019
Q3 | $54.4M | Buy |
1,072,760
+54,480
| +5% | +$2.56M | 6.82% | 8 |
|
|
2019
Q2 | $46.2M | Buy |
1,018,280
+513,930
| +102% | +$23.9M | 5.77% | 9 |
|
|
2019
Q1 | $24.1M | Buy |
504,350
+484,400
| +2,428% | +$24.1M | 3.76% | 10 |
|
|
2018
Q4 | $1.04M | Hold |
19,950
| – | – | 0.19% | 24 |
|
|
2018
Q3 | $1.24M | Hold |
19,950
| – | – | 0.19% | 24 |
|
|
2018
Q2 | $1.1M | Buy |
19,950
+200
| +1% | +$10.8K | 0.18% | 24 |
|
|
2018
Q1 | $1.25M | Buy |
19,750
+700
| +4% | +$45K | 0.2% | 24 |
|
|
2017
Q4 | $1.17M | Hold |
19,050
| – | – | 0.18% | 24 |
|
|
2017
Q3 | $1.21M | Sell |
19,050
-533
| -3% | -$31.1K | 0.19% | 24 |
|
|
2017
Q2 | $1.09M | Sell |
19,583
-9,000
| -31% | -$490K | 0.17% | 25 |
|
|
2017
Q1 | $1.55M | Hold |
28,583
| – | – | 0.27% | 23 |
|
|
2016
Q4 | $1.67M | Hold |
28,583
| – | – | 0.28% | 23 |
|
|
2016
Q3 | $1.54M | Hold |
28,583
| – | – | 0.28% | 23 |
|
|
2016
Q2 | $2.1M | Hold |
28,583
| – | – | 0.41% | 23 |
|
|
2016
Q1 | $1.83M | Buy |
28,583
+533
| +2% | +$33.6K | 0.34% | 23 |
|
|
2015
Q4 | $1.93M | Sell |
28,050
-750
| -3% | -$49.6K | 0.34% | 24 |
|
|
2015
Q3 | $1.7M | Hold |
28,800
| – | – | 0.32% | 24 |
|
|
2015
Q2 | $1.92M | Buy |
28,800
+400
| +1% | +$26.4K | 0.32% | 23 |
|
|
2015
Q1 | $1.83M | Hold |
28,400
| – | – | 0.31% | 23 |
|
|
2014
Q4 | $1.68M | Buy |
28,400
+750
| +3% | +$42.3K | 0.29% | 24 |
|
|
2014
Q3 | $1.42M | Hold |
27,650
| – | – | 0.23% | 27 |
|
|
2014
Q2 | $1.34M | Sell |
27,650
-2,000
| -7% | -$98.6K | 0.2% | 25 |
|
|
2014
Q1 | $1.54M | Buy |
29,650
+2,000
| +7% | +$106K | 0.22% | 23 |
|
|
2013
Q4 | $1.47M | Sell |
27,650
-650
| -2% | -$33.1K | 0.25% | 24 |
|
|
2013
Q3 | $1.31M | Sell |
28,300
-27,133
| -49% | -$1.19M | 0.19% | 28 |
|
|
2013
Q2 | $2.48M | Buy |
+55,433
| New | +$2.41M | 0.38% | 21 |
|
Other funds holding BMY
Kahn Brothers's BMY Position: Q2 2026 in Review
Kahn Brothers increased its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, buying an estimated $217K and bringing the position to 174,152 shares worth $10M. The position accounts for 1.59% of the portfolio, ranked #16.
Kahn Brothers first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $71.5M in Q2 2022. 2,506 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kahn Brothers held 174,152 shares of Bristol-Myers Squibb worth $10M as of Q2 2026.
- Kahn Brothers bought 3,771 Bristol-Myers Squibb shares in Q2 2026, an estimated $217K.
- Bristol-Myers Squibb made up 1.59% of Kahn Brothers's portfolio in Q2 2026, its #16 holding.
- Kahn Brothers first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Kahn Brothers's Bristol-Myers Squibb position peaked at $71.5M in Q2 2022.
- 2,506 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kahn Brothers Group's 13F filing for Q2 2026, filed 14 Aug 2026.